Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

How much heparin? A simple in vitro test

M Murphy1, S Leavey, P Burke

  • 1Department of Surgery, Royal College of Surgeons, Beaumont Hospital, Dublin, Republic of Ireland.

European Journal of Vascular Surgery
|July 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dysfunctional epicardial adipose tissue (EAT) and maladaptive heart remodeling in patients with increased visceral adiposity: the ST2/IL-33 cardio-fat signaling.

Journal of biological regulators and homeostatic agents·2019
Same author

Prediction of contrast induced acute kidney injury using novel biomarkers following contrast coronary angiography.

QJM : monthly journal of the Association of Physicians·2017
Same author

Heart-type fatty acid-binding protein (H-FABP) and highly sensitive troponin T (hsTnT) as markers of myocardial injury and cardiovascular events in elective percutaneous coronary intervention (PCI).

QJM : monthly journal of the Association of Physicians·2017
Same author

VEGF-related polymorphisms identified by GWAS and risk for major depression.

Translational psychiatry·2017
Same author

Epicardial adipocyte hypertrophy: Association with M1-polarization and toll-like receptor pathways in coronary artery disease patients.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2016
Same author

Twitter expands the reach and engagement of a national scientific meeting: the Irish Society of Urology.

Irish journal of medical science·2015

This study presents a simple in vitro test to determine optimal heparin dosage for surgery. The test accurately predicts in vivo anticoagulant response, allowing for individualized heparin dosing to improve patient outcomes.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology
  • Clinical Chemistry

Background:

  • Accurate heparin dosing is crucial for preventing thrombosis and hemorrhage during surgery.
  • Current methods for determining heparin dosage may not sufficiently account for individual patient variations.
  • Optimizing anticoagulation management is essential for improving surgical safety and efficacy.

Purpose of the Study:

  • To assess a simple in vitro test for calculating optimal heparin dosage for surgery.
  • To evaluate the correlation between in vitro heparin concentration and activated partial thromboplastin time (APTT).
  • To determine the feasibility of individualizing heparin anticoagulation based on in vitro testing.

Main Methods:

  • An in vitro test was developed using patient blood samples and varying heparin concentrations.

Related Experiment Videos

  • Activated partial thromboplastin time (APTT) was measured for each sample.
  • The natural logarithm of APTT was plotted against heparin concentration to establish a linear correlation.

    • Main Results:

    • The in vitro test calculated a median required heparin concentration (Hc) of 0.47 units/ml plasma.
    • Individualized intravenous heparin bolus doses ranged from 1000-2000 units (median 1500 units).
    • The mean in vivo APTT achieved was 77% of the predicted value, with a range of 62%-123%.

    Conclusions:

    • The developed in vitro test provides a reliable method for predicting in vivo heparin response.
    • This approach allows for more accurate and individualized anticoagulation dosage during surgery.
    • Implementing this test can enhance the safety and effectiveness of heparin therapy in surgical patients.